In: Current Oncology Reports, 2021, vol. 23, no. 3, p. 10
Purpose of Review Richter syndrome (RS) is an uncommon but aggressive evolution of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). RS is an unmet clinical need in the field of CLL. Recent advances in understanding the biology of this condition provide the rationale for testing new therapeutic concepts in order to improve the outcome of patients developing RS, which is so far...
|
In: Cancer Immunology, Immunotherapy, 2015, vol. 64, no. 8, p. 1033-1046
|
In: World Journal of Surgery, 2015, vol. 39, no. 7, p. 1767-1772
|
In: Annals of Hematology, 2015, vol. 94, p. 177-186
|
In: Journal of Hematopathology, 2015, vol. 8, no. 1, p. 13-20
|
In: European Archives of Oto-Rhino-Laryngology, 2015, vol. 272, no. 1, p. 123-129
|
In: Der Pathologe, 2015, vol. 36, no. 5, p. 467-476
|
In: International Journal of Colorectal Disease, 2015, vol. 30, no. 12, p. 1667-1675
|
In: Annals of Hematology, 2015, vol. 94, no. 11, p. 1899-1905
|
In: Leukemia, 2021, p. 7 p
The prognostic significance of lymphocyte doubling time (LDT) in chronic lymphocytic leukemia (CLL) was identified when the biology of the disease was poorly understood and therapy was not effective. We assessed the clinical and biological significance of LDT in 848 CLL patients in a real-life setting and the context of new biomarkers and effective therapy. A short LDT (≤12 months) was...
|